Małgorzata Gałecka

发表

Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders

J. Szemraj, A. Halaris, K. Su, 2022, Journal of clinical medicine.

Expression of p11 in Patients with Depression

J. Szemraj, P. Gałecki, A. Orzechowska, 2022, Journal of clinical medicine.

Ways of Coping with Stress among Patients with Depressive Disorders

A. Szulc, K. Su, P. Gałecki, 2022, Journal of clinical medicine.

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?

A. Szulc, P. Gałecki, A. Orzechowska, 2022, Biomedicines.

Update on the neurodevelopmental theory of depression: is there any ‘unconscious code’?

M. Maes, K. Su, P. Gałecki, 2020, Pharmacological Reports.

Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?

J. Szemraj, A. Halaris, K. Su, 2022, Journal of clinical medicine.

Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders—The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3

M. Maes, M. Berk, J. Szemraj, 2021, Journal of personalized medicine.

Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?

M. Maes, J. Szemraj, K. Su, 2020, Journal of clinical medicine.

Role of interleukin 17 (IL-17) in the inflammatory hypothesis of depression

A. Halaris, P. Gałecki, Katarzyna Bliźniewska-Kowalska, 2023, Journal of Affective Disorders Reports.

Single-Nucleotide Polymorphisms in Genes Maintaining the Stability of Mitochondrial DNA Affect the Occurrence, Onset, Severity and Treatment of Major Depressive Disorder

M. Bijak, J. Szemraj, T. Śliwiński, 2023, International journal of molecular sciences.

Emotional control in selected somatic and psychiatric diseases

D. Boduszek, P. Gałecki, A. Orzechowska, 2023, BMC Psychiatry.

The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A Literature Review

Angela Dziedzic, Katarzyna Bliźniewska-Kowalska, Małgorzata Gałecka, 2024, Nutrients.